Comments on The harmful effects of overlooking acute bacterial prostatitisAcute bacterial prostatitis (ABP) can progress to chronic inflammation in the absence of proper treatment with antibiotics and surgical drainage. This can lead to perineal discomfort and pain and prolong lower urinary tract symptoms, significantly affecting the patient's quality of life. 1 Yan et al. note that general physicians, rather than urologists, are more likely to encounter patients with ABP and often are the initial responders. The authors then provide a comprehensive review of how physicians can avoid missing the diagnosis of ABP and curative treatment options. 2 Additionally, they also explain the importance of cooperation, especially regarding treatment, as some conditions, such as cystostomy and transurethral resection, need to be managed by urologists and other specialists. 2 It is also important for urologists to be updated on the diagnosis and treatment of ABP. This is because many cases of ABP are caused by iatrogenic urinary tract infections, often triggered by urethral catheterization, surgery, or even transrectal prostate biopsy. It has been reported that approximately 80% of patients develop bacteremia during transurethral resection of the prostate if perioperative antibiotic prophylaxis is not used to prevent infection. 3 Furthermore, in case of a transrectal prostate biopsy, even if appropriate infection prevention and disinfection are performed, the possibility of ABP cannot be eliminated. Therefore, transperineal biopsy should be preferred over transrectal procedure, especially in patients with diabetes or those considered to be at greater risk for infection.Later, various studies have been conducted on the relationship between prostate inflammation and cancer development. Among these, carcinogenesis due to the intraprostatic microbiome has attracted attention; however, so far, the specific microbiome that causes prostate cancer has not been identified. On the other hand, in a recent large-scale epidemiological survey conducted on Koreans with a follow-up period of up to 10 years, patients with prostatitis had a higher incidence of prostate cancer than controls without inflammation, and patients were diagnosed with prostate cancer at an average of 4.7 years after developing prostatitis. 4 Hence, longterm follow-up may be required for patients with ABP.Furthermore, these patients had a higher incidence of prostate cancer than those with chronic prostatitis. 4 As mentioned above, the initial treatment for ABP is important, and appropriate measures are required. However, treatment can be difficult, particularly in patients with infections caused by drug-resistant bacteria. Therefore, in the future, detailed research on the development of new drugs and their routes of administration is necessary. We also hope that research on inflammation and cancer development in the prostate will progress and that effective methods for cancer prevention will emerge.